Gynaecomastia vs Man Boobs: Key Differences

Gynaecomastia vs man boobs is a distinction that matters clinically, yet the two terms are frequently confused. Gynaecomastia refers to the growth of true glandular breast tissue in men, driven by a hormonal imbalance, while 'man boobs' most often describes pseudogynaecomastia, an accumulation of excess fatty tissue in the chest without any glandular change. The two conditions look similar but have different causes, different investigations, and different treatment pathways. This article explains how to tell them apart, what causes each, and when to seek medical advice.

What is the difference between gynaecomastia and man boobs?

Gynaecomastia involves true glandular breast tissue growth beneath the nipple, while pseudogynaecomastia is excess chest fat with no glandular component; the two have different causes and treatment pathways.

Gynaecomastia is a medical condition involving the growth of actual glandular breast tissue in men, whereas the colloquial term 'man boobs' most often refers to excess fatty tissue (pseudogynaecomastia) that accumulates in the chest area without any glandular change. The term 'man boobs' is informal and some people find it stigmatising; the clinical term pseudogynaecomastia is preferred in a medical context. The distinction matters clinically because the two conditions have different causes, different investigations, and different treatment pathways.

In gynaecomastia, the breast gland itself enlarges, often producing a firm or rubbery disc of tissue beneath the nipple. This can affect one or both sides and may be accompanied by tenderness or sensitivity. Pseudogynaecomastia, by contrast, involves soft, fatty tissue distributed more broadly across the chest, and there is no palpable glandular lump beneath the nipple.

The two conditions can coexist, particularly in men who carry excess weight, which can make self-diagnosis unreliable. A healthcare professional can usually distinguish between them through clinical examination, and sometimes with imaging such as ultrasound. Understanding which condition is present is the essential first step before any treatment is considered.

The NHS and NICE CKS guidance on gynaecomastia provide further detail on definitions and clinical features.

What causes enlarged breast tissue in men?

Gynaecomastia is caused by an oestrogen-to-androgen imbalance from puberty, ageing, obesity, liver disease, or medicines such as spironolactone; pseudogynaecomastia is caused by excess body fat.

Gynaecomastia is caused by an imbalance between oestrogen and androgen (testosterone) activity in breast tissue, which stimulates glandular growth.^[1][9] This hormonal imbalance can arise from a wide range of causes, including puberty, older age, obesity, liver disease, kidney failure, hyperthyroidism, and tumours affecting the testes, adrenal glands or pituitary gland.

Medicines are a particularly common and often overlooked cause. Drugs associated with gynaecomastia include:^[2][3]

• Spironolactone (used for heart failure and fluid retention)

• Cimetidine (a histamine H2 blocker)

• Anabolic steroids and testosterone replacement therapy

• Some antipsychotics (for example, risperidone, which raises prolactin) and some antidepressants

• Certain chemotherapy agents

• Cannabis: an association has been reported, though the evidence is limited and causality is not firmly established^[10]

If you think a medicine you are taking may be contributing to breast changes, do not stop it without speaking to your GP first. Suspected side effects from prescribed medicines can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Pseudogynaecomastia, on the other hand, is caused primarily by excess body fat. As adipose tissue can convert androgens to oestrogens through a process called peripheral aromatisation, significant obesity can also contribute to true gynaecomastia, meaning the two conditions are not always entirely separate.^[1][9]

Physiological gynaecomastia occurs at predictable life stages: in newborns (due to maternal oestrogens), during puberty (a substantial proportion of adolescent boys are affected, and the condition usually resolves within two years), and in older men as testosterone levels naturally decline. When no underlying cause is identified, the condition is described as idiopathic.

The BNF and NICE CKS guidance on gynaecomastia list medicines associated with the condition and provide further detail on systemic causes.

How can you tell which condition you have?

A GP can distinguish the two by clinical examination, finding a firm subareolar disc in gynaecomastia versus diffuse soft tissue in pseudogynaecomastia, supported by blood tests and ultrasound if needed.

The most reliable way to distinguish gynaecomastia from pseudogynaecomastia is a clinical examination by a GP or specialist, though certain features can help guide your own assessment. In gynaecomastia, there is typically a firm, sometimes tender, disc-shaped lump of tissue directly beneath the nipple or areola. In pseudogynaecomastia, the chest feels soft throughout, with no distinct lump, and the enlargement tends to be more diffuse.

A GP will take a full medical history, including any medicines, supplements or recreational substances you use, and will examine both sides of the chest as well as the testes, since testicular abnormalities can be an underlying cause. They may arrange blood tests to check hormone levels (including testosterone, oestradiol, luteinising hormone, follicle-stimulating hormone, prolactin, and serum human chorionic gonadotrophin (hCG) where a tumour source is possible), liver and kidney function, and thyroid function. Testicular ultrasound may be requested if a testicular cause is suspected.

Breast ultrasound can help characterise breast tissue and identify features that may require further investigation, but it cannot on its own exclude malignancy. If imaging findings are suspicious, mammography and/or biopsy may be needed to reach a definitive diagnosis.

NICE guidance (NG12: Suspected cancer: recognition and referral) sets out criteria for urgent referral via the two-week-wait pathway for suspected breast cancer, including in men.^[14] Any man with a unilateral, hard, fixed or rapidly growing breast lump, nipple discharge, or skin changes should be referred promptly. If there is clinical uncertainty, a two-week-wait referral to a breast clinic should be considered. Patients and clinicians should refer to NG12 directly for the full age- and symptom-specific criteria.

Self-examination alone is not sufficient to make a diagnosis, and it is important not to delay seeking a professional opinion, particularly if the lump is one-sided, hard, fixed, or associated with nipple discharge or skin changes.

What treatment options are available on the NHS?

NHS treatment depends on the cause: drug review, watchful waiting, or off-label tamoxifen or raloxifene for glandular disease, and lifestyle modification or weight management for pseudogynaecomastia; surgery is available in severe cases via ICB funding.

Treatment for gynaecomastia on the NHS depends on the underlying cause, the duration of the condition, and the degree of physical or psychological impact. Where a medicine is responsible, the first step is usually to review and, where clinically safe, discontinue or substitute the causative drug. If an underlying medical condition such as hyperthyroidism or hypogonadism is identified, treating that condition may lead to resolution.

Physiological gynaecomastia in adolescents is usually managed with watchful waiting, as the majority of cases resolve spontaneously within one to two years. Reassurance and monitoring are the mainstay of management in this group.

For persistent or significant gynaecomastia, NHS treatment options include:

• Medical therapy: Medicines such as tamoxifen (an oestrogen receptor antagonist) or raloxifene are sometimes used off-label to reduce glandular tissue, particularly in early or active disease. These are not licensed for this indication, are generally initiated by a specialist rather than in primary care, and are most likely to be effective during the proliferative phase of the condition. Both carry risks that require individual discussion with a clinician; tamoxifen, for example, is associated with an increased risk of venous thromboembolism (VTE).^[12][13] Availability varies by Integrated Care Board (ICB) and these medicines are not universally commissioned for this purpose.

• Surgery: Surgical reduction (mastectomy or liposuction, depending on the tissue composition) may be considered for longstanding or severe cases causing significant distress. NHS commissioning of such procedures varies by ICB, and surgery for gynaecomastia is not routinely funded unless there is demonstrable psychological harm or an underlying medical indication. Patients may need to apply through their ICB's Individual Funding Request (IFR) process; your GP or specialist can advise on local pathways.

For pseudogynaecomastia, the primary NHS approach is lifestyle modification, including dietary change and increased physical activity, supported through NHS weight management services where appropriate. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, and is one option for those exploring medically supervised weight management alongside NHS care.

When should you see a GP about chest swelling or tenderness?

See a GP promptly for any new, one-sided, hard, fixed, or growing breast lump, nipple discharge, or skin changes, as these require assessment to exclude male breast cancer.

You should see a GP about chest swelling or tenderness if you notice a new lump beneath the nipple, particularly if it is one-sided, growing, hard, fixed to surrounding tissue, or accompanied by nipple discharge or skin changes. These features require prompt assessment to exclude male breast cancer, which, while uncommon, does occur and is more likely to present as a unilateral, painless, eccentric lump rather than the bilateral, tender, subareolar swelling typical of gynaecomastia.^[1][14]

Other reasons to consult a GP include:

• Breast tenderness or swelling that persists beyond two years in an adolescent^[1]

• New onset in an adult man with no obvious explanation

• Associated symptoms such as reduced libido, erectile dysfunction, fatigue, or testicular changes, which may suggest an underlying hormonal disorder

• Significant psychological distress, including anxiety, avoidance of social situations, or impact on quality of life

• Recent changes to prescribed medicines that coincide with the onset of breast changes

Contact your GP in the first instance for a routine or urgent appointment depending on your symptoms. If you are unsure whether your symptoms need same-day attention, NHS 111 can provide guidance. If you develop signs of a serious systemic illness alongside breast changes, such as high fever, rapidly spreading redness or swelling, or severe pain, seek same-day medical attention; call 999 if you are seriously unwell. A&E attendance is not necessary for breast swelling alone.

Early assessment is always preferable. Most cases of gynaecomastia are benign and manageable, but a timely diagnosis ensures that any treatable underlying cause is identified and that appropriate support, whether medical, surgical or psychological, can be put in place without unnecessary delay.

Scientific References

1. Gynaecomastia.
2. Spironolactone | Drugs - BNF - NICE.
3. Spironolactone 12.5 mg Film-coated Tablets.
4. Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials. Archivio italiano di urologia, andrologia..
5. Risperidone | Drugs - BNF - NICE.
6. Antipsychotic-Related Prolactin Levels and Sexual Dysfunction in Mentally Ill Youth: A 3-Month Cohort Study. Journal of the American Academy of Child and Adolescent Psychiatry..
7. Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study. Psychiatry Research..
8. [Hyperprolactinemia in mentally ill patients]. Acta Medica Portuguesa..
9. Drug-induced gynecomastia. Pharmacotherapy..
10. Gynecomastia and cannabis smoking. A nonassociation..
11. Tamoxifen | Drugs - BNF - NICE.
12. Tamoxifen 20mg Film-Coated Tablets.
13. Tamoxifen and risk of idiopathic venous thromboembolism..
14. Suspected cancer: recognition and referral (NG12).

Frequently Asked Questions